Camp4 Therapeutics (CAMP) Earnings Date & Reports

Camp4 Therapeutics Corp is a clinical stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics to upregulate gene expression and restore healthy protein levels to treat various genetic diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

CAMP is expected to report earnings to fall 120.26% to 46 cents per share on April 25

Camp4 Therapeutics CAMP Stock Earnings Reports

Q1'24

Est.

$0.46

Q4'23

Missed

by $2.27

Q3'23

Missed

by $0.14

Q2'23

Missed

by $0.15

Q1'23

Beat

by $0.04

The last earnings report on January 09 showed earnings per share of -226 cents, missing the estimate of 0 cents. With 109.43K shares outstanding, the current market capitalization sits at 43.14M.

View a ticker or compare two or three

Compare

CAMP